GLP-1 users should anticipate personal changes and take ownership to guide them during treatment
exhaust fumes, mold, parabens, phthalates, air pollution Heavy metal exposure i.e
Duration Throughout Treatment: Long-term side effects can persist throughout treatment or emerge after an extended use
We have noticed a similar upward trend in utilization and spend for GLP-1s across our book of business, with plan drug spend for Wegovy alone increasing over 500% between 2022 and 2023
Over recent years, demand for GLP-1 medications has outpaced supply, while pricing variability at retail pharmacies has created uncertainty for patients
In juxtaposition, the high prevalence of cannabis use alongside the rise in prescriptions of semaglutide for diabetes and obesity has led to concerns among cannabis users that their cannabis use could interfere with semaglutide therapeutic effects